Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What's been happening

What's been happening

posted on Mar 23, 2010 09:40PM

From prior press releases

10/9/09 Eclat to assist PTSC in search for CEO and to assist PDSG with completion of its business plan and acceleration of its revenue stream. Board expects a favorable independent tech assessment of PDSG's flagship CDX product within 2 weeks.

10/29/09 Eclat will launch a market validation study of CDX. This follows a completed independent assessment by a fortune 1000 tech firm in which CDX scored high marks

11/12/09 Restructure PDSG...exploit opportunity for CDX and Vigilys..divest ourselves of lameter

12/7/09 Mistry new board member. His track record for guiding innovative technologies to market is impressive. We will draw upon his insight and guidance as we shape the direction of this company (says Johnson).

1/28/10 ASHM (from stormking notes)

·PDSG – revs below expectations, engaged Eclat. Cognizant look at technical aspects of CDX.

·PTSC now has a clear understanding of next steps. Product quality is not the reason for failure of expectations. Things are difficult because:

·Small size of PTSC

·No name recognition

·Progress in getting partners is slow

·Economy

2 choices: Go it alone or partner up

Ecalt is looking for a partner

Per Cliff Flowers obtaining a CEO maybe 90-120 days out

Share
New Message
Please login to post a reply